MedPage Today on MSN2d
Type 2 Diabetes Patients Also Reap Benefits of Automated Insulin DeliveryOver 13 weeks, adults with type 2 diabetes using an automated insulin delivery (AID) system had a 0.6-percentage point ...
MedPage Today on MSN14d
FDA Approves Ocular Implant for Vision-Threatening MacTelThe FDA approved revakinagene taroretcel (Encelto) as the first treatment for adults with idiopathic macular telangiectasia ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback